Wockhardt ltd

The Estimates data displayed by Moneycontrol is not a recommendation to buy or sell any securities. The Company advises the users to check with duly registered and qualified advisors wockhardt ltd taking any investment decision. The Company or wockhardt ltd involved with the Company will not accept any liability for loss or damage as a result of reliance on the Estimates data. Note : Support and Resistance level for the day, calculated based on price range of the previous trading day, wockhardt ltd.

Powered by. Wockhardt Ltd Wockhardt is a pharmaceutical company that manufactures and markets vaccines, active pharmaceutical ingredients, formulations and biosimilars. Its product portfolio caters to various therapeutic areas including orthopedics, dental care, dermatology, rheumatology, gynecology, pediatrics, cardiology, pain management, nephrology, neurology and diabetes. Wockhardt is headquartered in Mumbai, Maharashtra, India. Bolster business development with timely opportunities.

Wockhardt ltd

Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai , India. It produces formulations , biopharmaceuticals , nutrition products, vaccines and active pharmaceutical ingredients APIs. Wockhardt was founded by Dr. Habil Khorakiwala in the s. Khorakiwala had acquired Worli Chemical Works [8] in This was incorporated as Wockhardt Pvt. In , it expanded into biotechnology , and subsequently started producing intravenous fluids. Reddy's joined the Indian Pharmaceutical Alliance as a founding member in an effort to promote the development of generic drugs in India. Wockhardt is the first company outside the US and Europe to manufacture recombinant human insulin. The contract was extended until August The board of directors, on 31 March approved the appointments of Habil Khorakiwala's sons Murtaza Khorakiwala and Huzaifa Khorakiwala as managing director and executive director respectively.

Pivot -. Select Item. Business Standard India.

Being different and making a difference. That sums up the vision, philosophy, conviction and driving force behind Dr. Habil F Khorakiwala who revels in venturing down the road less travelled. He founded Wockhardt in Our investors, Wockhardt shareowners, are an important and valued constituent of the Wockhardt stakeholder universe. While it is a matter of regulatory compliance, we also consider it as good governance and our duty and responsibility, to keep our investors informed and updated regularly about news, events and developments that impact our business and operations. Wockhardt is a leading, research-based, global enterprise with relevance in the fields of pharmaceuticals, biotechnology, and healthcare services.

Habil Khorakiwala founded Wockhardt in A member of the World Economic Forum, Dr. Khorakiwala has held many senior positions as an industry representative, and has been lauded and awarded by various institutions and organisations. He has also served as the President of IPA Indian Pharmaceutical Alliance ; as the Chairman of the Board of Governors at the Centre for Organisation Development in Hyderabad, a non-profit, scientific and industrial research organisation and a recognised doctoral research centre; and as the Chancellor of Jamia Hamdard University, New Delhi, which has emerged as an outstanding institution of higher learning with distinct and focused academic programmes. In , Dr. Independent Director Mr.

Wockhardt ltd

Being different and making a difference. That sums up the vision, philosophy, conviction and driving force behind Dr. Habil F Khorakiwala who revels in venturing down the road less travelled. He founded Wockhardt in Our investors, Wockhardt shareowners, are an important and valued constituent of the Wockhardt stakeholder universe. While it is a matter of regulatory compliance, we also consider it as good governance and our duty and responsibility, to keep our investors informed and updated regularly about news, events and developments that impact our business and operations. Wockhardt is a leading, research-based, global enterprise with relevance in the fields of pharmaceuticals, biotechnology, and healthcare services. WCK administered on compassionate ground and saved 20 lives. Now in Global phase III clinical trial.

Tsn fanduel sunday hosts

It produces formulations , biopharmaceuticals , nutrition products, vaccines and active pharmaceutical ingredients APIs. View More. Companies that have shown a fall in QoQ Profits as per their latest results. Retrieved 2 March New Drug Discovery. Innovation Wins. Market Position The Co. Wockhardt School. Follow Following. Pharmaceutical and biotechnology company headquartered in Mumbai, India. FII Buying. Business Standard. Wockhardt is a leading, research-based, global enterprise with relevance in the fields of pharmaceuticals, biotechnology, and healthcare services. Who is raising the stake and who is exiting? Posted by : attota.

Wockhardt is a true Indian multi-national company with a multi-ethnic workforce of 8, Wockhardt associates from 21 different nationalities globally.

View All. Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content. Retrieved 10 October Toggle limited content width. Cancel Submit. Wockhardt Foundation Associate Entity. Get detailed analysis with Moneycontrol Stock Insights. Make an informed investment decision with advanced AI-based features like SWOT analysis, investment checklist, technical ratings and know how fairly the company is valued. Research Wins. The Company or anyone involved with the Company will not accept any liability for loss or damage as a result of reliance on the Estimates data.